Plain-English translation of NCT05642182 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Psoriasis research guide →Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is a 24-week study testing SFA-002, a combination of natural substances, to see if it can safely help people with mild to moderate psoriasis plaques. Researchers will enroll up to 90 volunteers and test two different doses of the medication to measure its safety and how well it works. Blood tests and skin assessments will be performed throughout to track any benefits.
Current psoriasis treatments work well for some people but don't work for everyone, and some can have side effects. This study explores whether a naturally derived supplement might offer a gentler treatment option with a known safety profile for people with mild to moderate plaques.
You likely qualify if…
You likely don't qualify if…
You would take the medication for 12 weeks, then continue in the study for another 12 weeks of follow-up observation without the medication. During this time, you'll visit the clinic for blood draws and skin assessments to check for safety and any improvements in your psoriasis. The researchers will carefully monitor your progress and any side effects throughout the 6-month study period.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
United States